PIEX SOCIETE PHARMACEUTIQUE — Secnidazole Importer Profile
Pharmaceutical Importer · #5 buyer for Secnidazole · $624.1K import value · 23 shipments · FRANCE · DGFT Verified
PIEX SOCIETE PHARMACEUTIQUE is the #5 importer of Secnidazole from India with $624.1K in import value and 23 verified shipments. PIEX SOCIETE PHARMACEUTIQUE holds a 1.4% market share in Secnidazole imports based in FRANCE. The company sources from 2 verified suppliers across 20 formulations shipped to 1 country. Overall, PIEX SOCIETE PHARMACEUTIQUE imports 3 pharmaceutical products worth $1.1M across 3 therapeutic categories.
PIEX SOCIETE PHARMACEUTIQUE — Secnidazole Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Secnidazole to PIEX SOCIETE PHARMACEUTIQUE?
Verified from 23 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| IMPACT HEALTHCARE PRIVATE LIMITED | $537.7K | 18 | 86.2% |
| CROIENT PHARMA PRIVATE LIMITED | $86.3K | 5 | 13.8% |
PIEX SOCIETE PHARMACEUTIQUE sources Secnidazole from 2 verified Indian suppliers based on 23 customs records. The primary supplier is IMPACT HEALTHCARE PRIVATE LIMITED accounting for 86.2% of imports.
How Does PIEX SOCIETE PHARMACEUTIQUE Compare to Nearest Secnidazole Importers?
Buyers ranked immediately above and below #5 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | PLANET PHARMA SA | FRANCE | $900.0K | 18 | $50.0K |
| 2 | HEKO PHARMACY LTD | TANZANIA | $450.0K | 9 | $50.0K |
| 5 | PIEX SOCIETE PHARMACEUTIQUE ★ | FRANCE | $430.0K | 12 | $35.8K |
| 6 | NUEVOS ETICOS NEOETHICALS S A | GUATEMALA | $363.3K | 9 | $40.4K |
| 7 | PLANET PHARMA | FRANCE | $250.0K | 5 | $50.0K |
PIEX SOCIETE PHARMACEUTIQUE ranks #5 among 239 Secnidazole importers from India. Average shipment value of $35.8K compared to the market average of $23.0K. The closest competitors by value are PLANET PHARMA SA and HEKO PHARMACY LTD.
Where Does PIEX SOCIETE PHARMACEUTIQUE Import Secnidazole To?
Destination countries from 23 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $624.1K | 23 | 100.0% |
PIEX SOCIETE PHARMACEUTIQUE imports Secnidazole to 1 country. The primary destination is FRANCE receiving 100.0% of shipments worth $624.1K.
What Secnidazole Formulations Does PIEX SOCIETE PHARMACEUTIQUE Import?
| Formulation | Value | Shipments |
|---|---|---|
| AFSC KIT2 SECNIDAZOLE 1GM 1AZITHROMYCIN | $50.0K | 1 |
| AFSC KIT (2 SECNIDAZOLE 1GM 1 AZITHROMYCIN USP 1GM 1FLUCONAZOLE 150MG) ANTIFUNGAL DRUG B.NO.I2403005,MFG:11/23,EXP:10/25 | $50.0K | 1 |
| AFSC KIT SIZE : KIT B.NO. I2404002 MFG.DT: 03/2024 EXP.DT. 02/2026 (2 SECNIDAZOLE 1 GM,1 AZITHROMYCIN USP 1 GM, 1 | $50.0K | 1 |
| AFSC KIT SIZE : KIT B.NO. I2404005 MFG.DT. 06/2024 EXP.DT. 05/2026 (2 SECNIDAZOLE 1 GM,1 AZITHROMYCIN USP 1 GM, 1 | $50.0K | 1 |
| AFSC KIT 2 SECNIDAZOLE 1GM 1 AZITHROMYCIN USP 1GM 1 FLUCONAZOLE USP 150MG B NO I2405003 MFG 04 2025 EXP 03 2027 ANTIFUN | $50.0K | 1 |
| AFSC KIT(2 SECNIDAZOLE 1GM,1 AZITHROMYCIN USP 1GM,1 FLUCONAZOLE USP 150MG)B.NO.I2405002,MFG:02/2025,EXP:01/2027(ANTIFUNG | $41.2K | 1 |
| AFSC KIT2 Secnidazole 1Gm,1 Azithromyci | $40.9K | 1 |
| AFSC KIT SIZE : KIT B.NO. I2404003 MFG.DT. 03/2024 EXP.DT. 02/2026 (2 SECNIDAZOLE 1 GM,1 AZITHROMYCIN USP 1 GM, 1 FLUCON | $39.9K | 3 |
| ZIFLUSEC KIT (FLUCONOZOLE, AZITHROMYCIN,SECNIDAZOLE TABLETS COMBIKIT) BATCH NO:ETN4L03 MFG DT: 12/24 EXP DT: 11/27 | $34.3K | 1 |
| AFSC KIT(2 SECNIDAZOLE 1GM. 1 AZITHROMYCIN USP 1GM,1 FLUCONAZOLE USP 150MG)B.NO.I2405002,MFG:02/2025,EXP:01/2027(ANTIFUN | $33.0K | 1 |
PIEX SOCIETE PHARMACEUTIQUE imports 20 distinct Secnidazole formulations from India. The top formulation is AFSC KIT2 SECNIDAZOLE 1GM 1AZITHROMYCIN with 1 shipments worth $50.0K.
Who Are the Top Buyers of Secnidazole from India and How Much Does PIEX SOCIETE PHARMACEUTIQUE Import?
India exported $5.5M worth of Secnidazole through 652 shipments from 115 suppliers to 77 countries, serving 239 buyers globally. PIEX SOCIETE PHARMACEUTIQUE imports $624.1K of this total, accounting for 1.4% of India's Secnidazole exports with 23 shipments from FRANCE. This is verified from 23 customs shipment records covering 20 distinct formulations.
What Is the Average Order Value for PIEX SOCIETE PHARMACEUTIQUE's Secnidazole Imports?
PIEX SOCIETE PHARMACEUTIQUE's average Secnidazole order value is $27.1K per consignment, based on 23 shipments totaling $624.1K. PIEX SOCIETE PHARMACEUTIQUE is based in FRANCE and ranks #5 among all Secnidazole importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Secnidazole to PIEX SOCIETE PHARMACEUTIQUE?
PIEX SOCIETE PHARMACEUTIQUE sources Secnidazole from 2 verified Indian suppliers: IMPACT HEALTHCARE PRIVATE LIMITED ($537.7K, 86.2%), CROIENT PHARMA PRIVATE LIMITED ($86.3K, 13.8%). This is based on 23 customs records.
How Does PIEX SOCIETE PHARMACEUTIQUE Compare to Other Secnidazole Importers?
PIEX SOCIETE PHARMACEUTIQUE ranks #5 among 239 Secnidazole importers from India with a 1.4% market share. The top 3 importers are NUEVOS ETICOS NEOETHICALS, S.A. ($1.5M), PLANET PHARMA SA ($900.0K), HEKO PHARMACY LTD ($450.0K). PIEX SOCIETE PHARMACEUTIQUE processed 23 shipments from FRANCE.
About PIEX SOCIETE PHARMACEUTIQUE
PIEX SOCIETE PHARMACEUTIQUE imports 3 products worth $1.1M. Beyond Secnidazole, top products include Albendazole, Terbutaline. View the complete PIEX SOCIETE PHARMACEUTIQUE profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Secnidazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Secnidazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: PIEX SOCIETE PHARMACEUTIQUE matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as PIEX SOCIETE PHARMACEUTIQUE's capped import value divided by total capped export value for Secnidazole across all Indian exporters.
- 5.Verified Records: This page is backed by 23 individual customs records matching PIEX SOCIETE PHARMACEUTIQUE importing Secnidazole, covering 20 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 77+ countries, 239+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Secnidazole Import Data for PIEX SOCIETE PHARMACEUTIQUE
Access order-level details, pricing data, supplier connections, and competitive analysis for PIEX SOCIETE PHARMACEUTIQUE's Secnidazole imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
PIEX SOCIETE PHARMACEUTIQUE
Full Company Profile →
3 products · $1.1M total trade · 3 categories
PIEX SOCIETE PHARMACEUTIQUE × Secnidazole
Verified from customs records
Company Overview
Top Products by PIEX SOCIETE PHARMACEUTIQUE
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for PIEX SOCIETE PHARMACEUTIQUE.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Secnidazole. For current order-level data, contact TransData Nexus.